RJG-2051

RJG-2051 is a selective covalent SuTEx inhibitor of AKR1C3 with an IC50 of 13 nM that targets a noncatalytic tyrosine residue (Y24), effectively blocking its enzymatic activity and disrupting androgen, estrogen, and prostaglandin metabolism.

Price Not Available 1mg RJG-2051 Supplier Page
Catalog Number E8282
Molecular Formula C14H19ClN2O2
CAS# 2851993-77-4
Inchi InChI=1S/C14H19ClN2O2/c15-13-4-2-12(3-5-13)14(18)16-6-1-7-17-8-10-19-11-9-17/h2-5H,1,6-11H2,(H,16,18)
Inchi Key YYFGRAGNYHYWEZ-UHFFFAOYSA-N
SMILES C1COCCN1CCCNC(=O)C2=CC=C(C=C2)Cl
Size 1mg
Supplier Page http://www.selleckchem.com/products/rjg-2051.html
Additional Information https://file.selleck.cn/downloads/struct/E8282-RJG-2051-chemical-structure.png